Coronavirus (SARS-CoV-2): a systematic review for potential vaccines
Open Access
- 5 February 2021
- journal article
- review article
- Published by Taylor & Francis in Human Vaccines & Immunotherapeutics
- Vol. 18 (1) , 1865774
Abstract
COVID-19 is an international public health emergency in need of effective and safe vaccines for SARS-CoV-2. A systematic review has been done to analyze the availability, development and status of new COVID-19 vaccine candidates as well as the status of vaccines for other diseases that might be effective against SARS-CoV-2 infection. PubMed, MEDLINE, EMBASE, Science Direct, Google Scholar, Cochrane library, ClinicalTrials.gov, Web of Science and different trial registries were searched for currently available and probable future vaccines. Articles and ongoing clinical trials are included to ascertain the availability and developmental approaches of new vaccines that could limit the present and future outbreaks. Pharmaceutical companies and institutions are at different stages of developing new vaccines, and extensive studies and clinical trials are still required.Keywords
Funding Information
- received for this research
This publication has 51 references indexed in Scilit:
- SARS veterans tackle coronavirusNature, 2012
- A computer simulation of vaccine prioritization, allocation, and rationing during the 2009 H1N1 influenza pandemicVaccine, 2010
- Serum α1-acid glycoprotein (AGP) concentration in non-symptomatic cats with feline coronavirus (FCoV) infectionJournal of Feline Medicine and Surgery, 2007
- Canine coronavirus induces apoptosis in cultured cellsVeterinary Microbiology, 2007
- Therapy with a Severe Acute Respiratory Syndrome–Associated Coronavirus–Neutralizing Human Monoclonal Antibody Reduces Disease Severity and Viral Burden in Golden Syrian HamstersThe Journal of Infectious Diseases, 2006
- Monoclonal antibodies to SARS-associated coronavirus (SARS-CoV): Identification of neutralizing and antibodies reactive to S, N, M and E viral proteinsJournal of Virological Methods, 2005
- Development and Characterization of a Severe Acute Respiratory Syndrome–Associated Coronavirus–Neutralizing Human Monoclonal Antibody That Provides Effective Immunoprophylaxis in MiceThe Journal of Infectious Diseases, 2005
- Severe acute respiratory syndrome vaccine development: experiences of vaccination against avian infectious bronchitis coronavirusAvian Pathology, 2003
- Antibody-Dependent Enhancement of Virus Infection and DiseaseViral Immunology, 2003
- Virology: CoronavirusesNature, 1968